CIK 0001707502
- Non-accelerated filer
- Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900943402
- Phone
- +1 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-27 | Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy | Exercise or conversion | +11,500 | 339,109 | ||
| 2021-01-27 | Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy | Exercise or conversion · Restricted Stock Units | −11,500 | 0 | ||
| 2021-01-27 | Morris Carl Ashley Chief Scientific Officer | Exercise or conversion | +11,500 | 302,459 | ||
| 2021-01-27 | Morris Carl Ashley Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −11,500 | 0 | ||
| 2021-01-27 | Ganot Ilan CEO & President | Exercise or conversion | +35,500 | 1,210,534 | ||
| 2021-01-27 | Ganot Ilan CEO & President | Exercise or conversion · Restricted Stock Units | −35,500 | 0 | ||
| 2021-01-25 | Schneider Joel Solomon Zev Chief Technology Officer | Grant or award · Employee Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2021-01-25 | Ganot Ilan CEO & President | Grant or award · Employee Stock Option (Right to Buy) | +438,000 | 438,000 | ||
| 2021-01-25 | Ganot Ilan CEO & President | Grant or award · Employee Stock Option (Right to Buy) | +8,100 | 8,100 | ||
| 2021-01-25 | Morris Carl Ashley Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2021-01-04 | SMITH IAN F Director | Grant or award · Stock Option (Right to Buy) | +389,000 | 389,000 | ||
| 2020-12-10 | PERCEPTIVE ADVISORS LLC Director | Grant or award | +4,054,054 | $3.70 | $15.0M | 10,803,857 |
| 2020-12-10 | SMITH IAN F Director | Grant or award | +270,270 | $3.70 | $1000K | 270,270 |
| 2020-12-10 | Ganot Ilan CEO & President | Grant or award | +27,027 | $3.70 | $100K | 1,175,034 |
| 2020-12-10 | Arnold Matthew Bennett Director | Grant or award | +432,432 | $3.70 | $1.6M | 3,933,429 |
| 2020-12-10 | Shah Rajeev M. Director | Grant or award | +4,938,282 | $3.70 | $18.3M | 8,709,882 |
| 2020-12-10 | Koppel Adam Director | Grant or award | +3,189,189 | $3.70 | $11.8M | 7,060,353 |
| 2020-08-13 | Ganot Ilan CEO & President | Sale | −299 | $2.44 | $730 | 3,483 |
| 2020-08-12 | Ganot Ilan CEO & President | Exercise or conversion | +800 | 3,737 | ||
| 2020-08-12 | Ganot Ilan CEO & President | Exercise or conversion · Restricted Stock Units | −800 | 0 |
Page 23 of 31 · 604 trades